SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-062262
Filing Date
2013-08-09
Accepted
2013-08-09 14:48:29
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-13986_110q.htm 10-Q 1181290
2 EX-31.1 a13-13986_1ex31d1.htm EX-31.1 11887
3 EX-31.2 a13-13986_1ex31d2.htm EX-31.2 11323
4 EX-32.1 a13-13986_1ex32d1.htm EX-32.1 6071
5 EX-32.2 a13-13986_1ex32d2.htm EX-32.2 6169
  Complete submission text file 0001104659-13-062262.txt   14403437

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abbv-20130630.xml EX-101.INS 1529826
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20130630.xsd EX-101.SCH 83899
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abbv-20130630_cal.xml EX-101.CAL 86740
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20130630_def.xml EX-101.DEF 476303
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT abbv-20130630_lab.xml EX-101.LAB 1472332
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20130630_pre.xml EX-101.PRE 771551
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35565 | Film No.: 131026138
SIC: 2834 Pharmaceutical Preparations